标题
Diabetes and Novel Coronavirus Infection: Implications for Treatment
作者
关键词
-
出版物
Diabetes Therapy
Volume -, Issue -, Pages -
出版商
Springer Science and Business Media LLC
发表日期
2020-07-13
DOI
10.1007/s13300-020-00858-2
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options
- (2020) Suliman Khan et al. JOURNAL OF CLINICAL MICROBIOLOGY
- A pneumonia outbreak associated with a new coronavirus of probable bat origin
- (2020) Peng Zhou et al. NATURE
- Functional assessment of cell entry and receptor usage for SARS-CoV-2 and other lineage B betacoronaviruses
- (2020) Michael Letko et al. Nature Microbiology
- Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations
- (2020) Yanan Cao et al. Cell Discovery
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes
- (2020) Lihua Zhu et al. Cell Metabolism
- Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
- (2020) Wanbo Tai et al. Cellular & Molecular Immunology
- Association of Inpatient Use of Angiotensin Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers with Mortality Among Patients With Hypertension Hospitalized With COVID-19
- (2020) Peng Zhang et al. CIRCULATION RESEARCH
- Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China
- (2020) Bo Li et al. Clinical Research in Cardiology
- COVID ‐19 infection may cause ketosis and ketoacidosis
- (2020) Juyi Li et al. DIABETES OBESITY & METABOLISM
- Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed
- (2020) Aihong Wang et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- COVID-19 and diabetes: Can DPP4 inhibition play a role?
- (2020) Gianluca Iacobellis DIABETES RESEARCH AND CLINICAL PRACTICE
- COVID-19 and diabetes: Knowledge in progress
- (2020) Akhtar Hussain et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?
- (2020) Rimesh Pal et al. DIABETES RESEARCH AND CLINICAL PRACTICE
- Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory
- (2020) Antonio Ceriello DIABETES RESEARCH AND CLINICAL PRACTICE
- DPP4 inhibition: preventing SARS‐CoV ‐2 infection and/or progression of COVID ‐19?
- (2020) Rocky Strollo et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Endocrine and metabolic link to coronavirus infection
- (2020) Stefan R. Bornstein et al. Nature Reviews Endocrinology
- Multiorgan and Renal Tropism of SARS-CoV-2
- (2020) Victor G. Puelles et al. NEW ENGLAND JOURNAL OF MEDICINE
- Liraglutide Attenuates Non-Alcoholic Fatty Liver Disease in Mice by Regulating the Local Renin-Angiotensin System
- (2020) Mengying Yang et al. Frontiers in Pharmacology
- Prevalence and impact of diabetes among people infected with SARS-CoV-2
- (2020) G. P. Fadini et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?
- (2020) Lei Fang et al. Lancet Respiratory Medicine
- Drug Therapy in Obesity: A Review of Current and Emerging Treatments
- (2020) David M. Williams et al. Diabetes Therapy
- Diabetic patients with COVID-19 infection are at higher risk of ICU admission and poor short-term outcome
- (2020) Loris Roncon et al. JOURNAL OF CLINICAL VIROLOGY
- Letter to the Editor: Diabetes patients with COVID-19 need better blood glucose management in Wuhan, China
- (2020) Jun Zhou et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Practical recommendations for the management of diabetes in patients with COVID-19
- (2020) Stefan R Bornstein et al. Lancet Diabetes & Endocrinology
- COVID-19: underlying metabolic health in the spotlight
- (2020) The Lancet Diabetes & Endocrinology Lancet Diabetes & Endocrinology
- From SARS to MERS, Thrusting Coronaviruses into the Spotlight
- (2019) Zhiqi Song et al. Viruses-Basel
- Diuretic Effects of Sodium Glucose Cotransporter 2 Inhibitors and Their Influence on the Renin-Angiotensin System
- (2019) Tuba M. Ansary et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Time trends in prescribing of type 2 diabetes drugs, glycemic response and risk factors: a retrospective analysis of primary care data, 2010‐2017
- (2019) John M Dennis et al. DIABETES OBESITY & METABOLISM
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Renal Outcomes in Type 2 Diabetes: A Review of Cardiovascular and Renal Outcome Trials
- (2019) David M. Williams et al. Diabetes Therapy
- A review of dipeptidyl peptidase-4 inhibitors. Hot topics from randomized controlled trials
- (2018) Carolyn F. Deacon DIABETES OBESITY & METABOLISM
- Mortality from infectious diseases in diabetes
- (2018) G. Zoppini et al. NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES
- Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: the potential contribution to diabetes complications and cardiovascular disease
- (2018) Fabrice Bonnet et al. DIABETES & METABOLISM
- Origin and evolution of pathogenic coronaviruses
- (2018) Jie Cui et al. NATURE REVIEWS MICROBIOLOGY
- Mast Cell and M1 Macrophage Infiltration and Local Pro-Inflammatory Factors Were Attenuated with Incretin-Based Therapies in Obesity-Related Glomerulopathy
- (2017) Jiao He et al. Metabolic Syndrome and Related Disorders
- Cut to the chase: a review of CD26/dipeptidyl peptidase-4's (DPP4) entanglement in the immune system
- (2016) C. Klemann et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Can a Shift in Fuel Energetics Explain the Beneficial Cardiorenal Outcomes in the EMPA-REG OUTCOME Study? A Unifying Hypothesis
- (2016) Sunder Mudaliar et al. DIABETES CARE
- Diabetes and infection: assessing the association with glycaemic control in population-based studies
- (2016) Jonathan Pearson-Stuttard et al. Lancet Diabetes & Endocrinology
- Risk factors for severity and mortality in patients with MERS-CoV: Analysis of publicly available data from Saudi Arabia
- (2016) Gouri Rani Banik et al. VIROLOGICA SINICA
- Euglycemic Diabetic Ketoacidosis: A Predictable, Detectable, and Preventable Safety Concern With SGLT2 Inhibitors
- (2015) Julio Rosenstock et al. DIABETES CARE
- Activation of the GLP-1 Receptor by Liraglutide Increases ACE2 Expression, Reversing Right Ventricle Hypertrophy, and Improving the Production of SP-A and SP-B in the Lungs of Type 1 Diabetes Rats
- (2015) Marina Romaní-Pérez et al. ENDOCRINOLOGY
- Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
- (2015) Bernard Zinman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Incretin-Based Therapies, Glucometabolic Health and Endovascular Inflammation
- (2014) Manfredi Rizzo et al. CURRENT PHARMACEUTICAL DESIGN
- Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC
- (2013) V. Stalin Raj et al. NATURE
- Diabetes and Infection: Is There a Link? - A Mini-Review
- (2012) Sylvia Knapp GERONTOLOGY
- Isolation of a Novel Coronavirus from a Man with Pneumonia in Saudi Arabia
- (2012) Ali M. Zaki et al. NEW ENGLAND JOURNAL OF MEDICINE
- A novel approach to control hyperglycemia in type 2 diabetes: Sodium glucose co-transport (SGLT) inhibitors. Systematic review and meta-analysis of randomized trials
- (2011) Giovanni Musso et al. ANNALS OF MEDICINE
- Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17β-oestradiol-dependent and sex chromosome-independent
- (2010) Jun Liu et al. Biology of Sex Differences
- Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes
- (2009) Jin-Kui Yang et al. ACTA DIABETOLOGICA
- Association of insertion/deletion polymorphism of angiotensin-converting enzyme gene with essential hypertension and type 2 diabetes mellitus in Malaysian subjects
- (2009) Vasudevan Ramachandran et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation